Evidence map›Paper›PMID 30261639›Full record

ArticleCells2018

Yifat Yanku, Eliya Bitman-Lotan, Yaniv Zohar, Estee Kurant, Norman Zilke, Martin Eilers, Amir Orian

Open access · goldAbstract read
In one paragraph

Article in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Yifat YankuRappaport Research Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel. yifaty@technion.ac.il.
Eliya Bitman-LotanRappaport Research Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel. eliyabit@technion.ac.il.
Yaniv ZoharRappaport Research Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel. yanivz75@gmail.com.
Estee KurantFaculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel. ekurant@univ.haifa.ac.il.ORCID 0000-0003-4795-4074
Norman ZilkeGenome-Scale Biology Research Program Institute of Biomedicine University of Helsinki, 00290 Helsinki, Finland. norman.zielke@helsinki.fi.
Martin EilersTheodor Boveri Institute, Biocenter, University of Würzburg, D-97074 Würzburg, Germany. martin.eilers@biozentrum.uni-wuerzburg.de.
Amir OrianRappaport Research Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel. mdoryan@tx.technion.ac.il.
Technion – Israel Institute of Technology · ILUniversity of Haifa · ILUniversity of Helsinki · FIUniversity of Würzburg · DE

Funding

German-Israeli Foundation for Scientific Research and Development 3672.13The Flinkman-Marandy family grant for cancer research AO001
6 · The paper itself

Abstract

The HECT-type ubiquitin ligase HECT, UBA and WWE Domain Containing 1, (HUWE1) regulates key cancer-related pathways, including the Myc oncogene. It affects cell proliferation, stress and immune signaling, mitochondria homeostasis, and cell death. HUWE1 is evolutionarily conserved from

Indexed as

dmP53dMycendoreplicationHECTHUWE1JNKsalivary glandubiquitin

Identifiers

PMID30261639
PMCPMC6210797
OpenAlexW2893682122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.